MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL AND RELATED METHODS
First Claim
1. A non-naturally occurring microbial organism, comprising a microbial organism having a 1,4-butanediol (BDO) pathway comprising at least one exogenous nucleic acid encoding a BDO pathway enzyme expressed in a sufficient amount to produce BDO, wherein said microbial organism is genetically modified to express exogenous succinyl-CoA synthetase;
- to express exogenous alpha-ketoglutarate decarboxylase;
to express exogenous succinate semialdehyde dehydrogenase and 4-hydroxybutyrate dehydrogenase and optionally 4-hydroxybutyryl-CoA/acetyl-CoA transferase;
to express exogenous butyrate kinase and phosphotransbutyrylase;
to express exogenous 4-hydroxybutyryl-CoA reductase; and
to express exogenous 4-hydroxybutanal reductase;
to express exogenous pyruvate dehydrogenase;
to disrupt a gene encoding an aerobic respiratory control regulatory system;
to express an exogenous NADH insensitive citrate synthase;
to express exogenous phosphoenolpyruvate carboxykinase.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides non-naturally occurring microbial organisms comprising a 1,4-butanediol (BDO) pathway comprising at least one exogenous nucleic acid encoding a BDO pathway enzyme expressed in a sufficient amount to produce BDO and further optimized for expression of BDO. The invention additionally provides methods of using such microbial organisms to produce BDO.
-
Citations
37 Claims
-
1. A non-naturally occurring microbial organism, comprising a microbial organism having a 1,4-butanediol (BDO) pathway comprising at least one exogenous nucleic acid encoding a BDO pathway enzyme expressed in a sufficient amount to produce BDO, wherein said microbial organism is genetically modified to express exogenous succinyl-CoA synthetase;
- to express exogenous alpha-ketoglutarate decarboxylase;
to express exogenous succinate semialdehyde dehydrogenase and 4-hydroxybutyrate dehydrogenase and optionally 4-hydroxybutyryl-CoA/acetyl-CoA transferase;
to express exogenous butyrate kinase and phosphotransbutyrylase;
to express exogenous 4-hydroxybutyryl-CoA reductase; and
to express exogenous 4-hydroxybutanal reductase;
to express exogenous pyruvate dehydrogenase;
to disrupt a gene encoding an aerobic respiratory control regulatory system;
to express an exogenous NADH insensitive citrate synthase;
to express exogenous phosphoenolpyruvate carboxykinase. - View Dependent Claims (2, 10, 11, 12, 13, 16, 17, 18, 19, 27, 28, 29, 32, 33, 34, 35, 37)
- to express exogenous alpha-ketoglutarate decarboxylase;
-
3-9. -9. (canceled)
-
14-15. -15. (canceled)
-
20-26. -26. (canceled)
-
30-31. -31. (canceled)
-
36. A non-naturally occurring microbial organism, comprising a microbial organism having a 1,4-butanediol (BDO) pathway comprising at least one exogenous nucleic acid encoding a BDO pathway enzyme expressed in a sufficient amount to produce BDO, wherein said microbial organism is genetically modified as in any of strains 3-20 of Table 28.
Specification